Key clinical point: Halting antiseizure medications is safe after acute symptomatic neonatal seizures.
Major finding: Functional development measures were similar with discontinued and maintenance therapy.
Study details: Prospective, observational, comparative effectiveness study of 270 patients at nine centers enrolled in the Neonatal Seizure Registry.
Disclosures: The study was funded by the Patient-Centered Outcomes Research Institute (PCORI) and the Pediatric Epilepsy Research Foundation. Dr. Glass has no other financial relationships to disclose.
Glass HC et al. CNS-ICNA 2020. Presentation PL58.